Related Experiment Video

Updated: Jul 10, 2026

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells
09:45

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells

Published on: May 21, 2019

Small interfering RNA (siRNA) inhibited human liver cancer cell line SMMC7721 proliferation and tumorigenesis

Lu Dong-Dong1

  • 1Tongji University School of Life Science and Technology, Shanghai, PR China. Ludondon88@163.com

Hepato-Gastroenterology
|November 21, 2007
PubMed
Abstract

Insights

AKR1C2 small interfering RNA (siRNA) inhibits liver cancer cell proliferation and tumor growth. This study shows AKR1C2 siRNA alters cell cycle and blocks hepatocarcinogenesis in SMMC7721 cells.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Regulation

Background:

  • Hepatocellular carcinoma (HCC) remains a significant global health challenge.
  • Understanding the molecular mechanisms driving HCC is crucial for developing effective therapies.
  • The role of Aldo-keto Reductase Family 1 Member C2 (AKR1C2) in liver cancer is not fully elucidated.

Purpose of the Study:

  • To investigate the impact of AKR1C2 small interfering RNA (siRNA) on the proliferation and tumorigenesis of the human liver cancer cell line SMMC7721.
  • To determine the potential of AKR1C2 as a therapeutic target for blocking hepatocarcinogenesis.

Main Methods:

  • Construction and transfection of an AKR1C2 siRNA expression vector (pGenesil-1/AKR1C2 RNAi) into SMMC7721 cells.
  • Assessment of cell proliferation using MTT assay.
  • Analysis of cell cycle distribution via flow cytometry.
  • Evaluation of colony-formation efficiency and in vivo tumorigenesis.

Main Results:

  • Stable transfection with AKR1C2 siRNA led to a significant increase in G0/G1 phase cells and a decrease in S and G2/M phase cells.
  • AKR1C2 siRNA significantly inhibited SMMC7721 cell proliferation (p < 0.01).
  • Reduced colony-formation efficiency and decreased tumor formation ability in vivo were observed.

Conclusions:

  • AKR1C2 siRNA induces alterations in the SMMC7721 cell cycle.
  • AKR1C2 siRNA effectively inhibits tumor growth both in vitro and in vivo.
  • These findings suggest AKR1C2 siRNA plays a critical role in blocking hepatocarcinogenesis, highlighting its potential as a therapeutic strategy.

More Related Videos

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

DNA Vector-based RNA Interference to Study Gene Function in Cancer13:10

DNA Vector-based RNA Interference to Study Gene Function in Cancer

Published on: June 4, 2012

Related Concept Videos

siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
Small interfering RNAs (siRNA)02:30

Small interfering RNAs (siRNA)

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...